|
Current
Studies
The
clinical
trials
group at
Somerset
Skin
Centre
is
currently
recruiting
participants
for
several
studies,
psoriasis,
atopic
dermatitis,
and skin
infection.
Psoriasis
studies:
The
breakthroughs
in the
treatment
of
psoriasis
are the
new
biologics
developed
to
combat
this
skin
condition.
Some are
taken by
injection,
either
in the
doctor’s
office
or by
the
patient
at
home.
Another
type of
biologic
therapy
is taken
by
infusion
in the
doctor’s
office.
If you
are
currently
on a
biologic,
or are
interested
in
learning
more
about
them,
please
contact
us.
Patients
diagnosed
with
chronic
moderate
or severe
plaque
psoriasis
may be
eligible
to be in
a study
which is
following
patients
for 5
years to
track
the long
term
benefits
and
effects
of
treatment
with
biologics.
Patients
are
given a
gift
card in
return
for
their
time
spent
answering
questions
about
their
condition.
-
RAPTIVA:
Epidemiologic
study
of
psoriasis
outcomes
and
safety
events
(RESPONSE)
in
patients
with
chronic
moderate
to
severe
plaque
psoriasis
-
ATLAS:
Assessment
and
tracking
of
long-term
alafacept
Eczema studies:
If you
have
been
treated
for
atopic
dermatitis
with
tacrolimus
ointment
(protopic),
and the
first
use was
before
the age
of 16,
you can
participate
in a
study to
assess
the
long-term
safety
of
tacrolimus
ointment
for the
treatment
of
atopic
dermatitis.
Your
atopic
dermatitis
does not
have to
be
active
to
participate.
-
APPLES:
A
prospective
pediatric
longitudinal
evaluation
to
assess
the
long-term
safety
of
tacrolimus
ointment
for the
treatment
of
atopic
dermatitis
Skin Infection studies:
The
effectiveness
of two
types of
antibiotics
on skin
infections
are
being
studied.
Patients
with
lesions
with at
least 2
of the
following
clinical
signs
are
eligible;
pain/tenderness;
erythema/warmth;
swelling;
induration;
or
fluctuation.
-
A
randomized,
investigator-blind
study
to
evaluate
the
effectiveness
of oral
cefdinir
(Omnicef)
once
daily
versus
oral
cephalexin
four
times
daily
for the
treatment
of
uncomplicated
skin
and
skin
structure
infections
(USSSIs)
If you
are
interested
in
learning
more
about
any of
these
studies,
please
contact
Dianna
Fortunato
at
248-244-8448.
|
